使用新型纳米治疗药物抑制CD154:CD11b相互作用改善了全移植存活率
Hongmin Yao1, Alexandra Bahn-Humphrey1, Danya Liu1
1Department of Surgery, Emory University School of Medicine, Atlanta, Georgia, USA.
概括
针对CD154:CD11b的新型纳米颗粒与CTLA-4Ig协同作用,通过减少T细胞反应和延长全移植存活时间来增强移植耐受性.
科学领域:
- 免疫学 免疫学 免疫学
- 移植生物学 移植生物学
- 纳米医学是一种纳米医学.
背景情况:
- CD154 (也称为CD40连接体) 与CD40的相互作用是免疫反应的关键途径.
- CD154还与CD11b结合,在移植中提供了一个独特的治疗点.
- 之前的研究表明,结合抗CD40和CD154:CD11b阻断可以提高全移植存活率.
研究的目的:
- 为了研究一种基于纳米粒子的新方法来实现CD154:CD11b封锁.
- 在移植模型中评估CD154:CD11b阻断纳米颗粒与CTLA-4Ig结合的疗效.
- 评估对T细胞反应和长期异位移植耐受性的影响.
主要方法:
- 使用过的氨酸纳米颗粒结合的CD154:CD11b抑制剂 (iPepHANP).
- 将IpepHANP与CTLA-4Ig结合给所有基性皮肤移植的接受者.
- 分析了脏和皮肤全移植中的 CD4+ 和 CD8+ T 细胞对捐赠者的反应反应.
- 通过二次移植再试验评估长期移植耐受性.
主要成果:
- iPepHANP与CTLA-4Ig协同作用,显著延长异种移植的存活时间.
- 联合治疗显著降低了脏中对供体反应的CD4+和CD8+T细胞的频率.
- 减少了捐赠者反应性CD4+ T细胞和激活的CD8+ T细胞的透到皮肤全移植中.
- 经过100天的治疗和二次移植复试后观察到持续的移植耐受性.
结论:
- CD154:CD11b阻断纳米颗粒代表了移植的有前途的治疗策略.
- 纳米粒子方法有效地提供CD154:CD11b阻断,增强免疫抑制.
- 这种策略有可能在没有持续免疫抑制的情况下诱导长期移植耐受性.
相关概念视频
Feedback Inhibition
57.2K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.2K
Survival Curves
719
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
719
Survival Tree
433
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a...
Building a Survival Tree
Constructing a...
433
Introduction To Survival Analysis
795
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
795
Comparing the Survival Analysis of Two or More Groups
605
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
605
Truncation in Survival Analysis
622
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
622


